Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Daily Top 10 COVID-19 papers


  Liver Transplantation

  Free Subscription

Articles published in PLoS One

Retrieve available abstracts of 114 articles:
HTML format

Single Articles

    January 2020
  1. MUNSHI VN, Saghafian S, Cook CB, Werner KT, et al
    Comparison of post-transplantation diabetes mellitus incidence and risk factors between kidney and liver transplantation patients.
    PLoS One. 2020;15:e0226873.
    PubMed     Abstract available

  2. TRON C, Woillard JB, Houssel-Debry P, David V, et al
    Pharmacogenetic-Whole blood and intracellular pharmacokinetic-Pharmacodynamic (PG-PK2-PD) relationship of tacrolimus in liver transplant recipients.
    PLoS One. 2020;15:e0230195.
    PubMed     Abstract available

  3. PFLUGRAD H, Nosel P, Ding X, Schmitz B, et al
    Brain function and metabolism in patients with long-term tacrolimus therapy after kidney transplantation in comparison to patients after liver transplantation.
    PLoS One. 2020;15:e0229759.
    PubMed     Abstract available

  4. STEGGERDA JA, Bloom MB, Noureddin M, Brennan TV, et al
    Higher thresholds for the utilization of steatotic allografts in liver transplantation: Analysis from a U.S. national database.
    PLoS One. 2020;15:e0230995.
    PubMed     Abstract available

    January 2019
  5. MOON YJ, Kim JW, Bang YS, Lim YS, et al
    Prediction of all-cause mortality after liver transplantation using left ventricular systolic and diastolic function assessment.
    PLoS One. 2019;14:e0209100.
    PubMed     Abstract available

  6. AVOLIO AW, Gaspari R, Teofili L, Bianco G, et al
    Postoperative respiratory failure in liver transplantation: Risk factors and effect on prognosis.
    PLoS One. 2019;14:e0211678.
    PubMed     Abstract available

  7. SKOGLUND C, Lagging M, Castedal M
    No need to discontinue hepatitis C virus therapy at the time of liver transplantation.
    PLoS One. 2019;14:e0211437.
    PubMed     Abstract available

  8. LIU B, Anno K, Kobayashi T, Piao J, et al
    Influence of donor liver telomere and G-tail on clinical outcome after living donor liver transplantation.
    PLoS One. 2019;14:e0213462.
    PubMed     Abstract available

  9. Correction: Prediction of all-cause mortality after liver transplantation using left ventricular systolic and diastolic function assessment.
    PLoS One. 2019;14:e0213967.
    PubMed     Abstract available

  10. BOECKER J, Czigany Z, Bednarsch J, Amygdalos I, et al
    Potential value and limitations of different clinical scoring systems in the assessment of short- and long-term outcome following orthotopic liver transplantation.
    PLoS One. 2019;14:e0214221.
    PubMed     Abstract available

  11. PARK J, Lee J, Kwon A, Choi HJ, et al
    The 2016 ASE/EACVI recommendations may be able to more accurately identify patients at risk for diastolic dysfunction in living donor liver transplantation.
    PLoS One. 2019;14:e0215603.
    PubMed     Abstract available

  12. MEISCHL T, Rasoul-Rockenschaub S, Gyori G, Sieghart W, et al
    C-reactive protein is an independent predictor for hepatocellular carcinoma recurrence after liver transplantation.
    PLoS One. 2019;14:e0216677.
    PubMed     Abstract available

  13. Retraction: Downgrading MELD Improves the Outcomes after Liver Transplantation in Patients with Acute-on-Chronic Hepatitis B Liver Failure.
    PLoS One. 2019;14:e0220487.

  14. LEEK RB, Park JM, Koerschner C, Mawby J, et al
    Novel educational and goal-setting tool to improve knowledge of chronic kidney disease among liver transplant recipients: A pilot study.
    PLoS One. 2019;14:e0219856.
    PubMed     Abstract available

  15. Retraction: De novo Cancers Following Liver Transplantation: A Single Center Experience in China.
    PLoS One. 2019;14:e0220430.

  16. Retraction: A Scoring Model Based on Neutrophil to Lymphocyte Ratio Predicts Recurrence of HBV-Associated Hepatocellular Carcinoma after Liver Transplantation.
    PLoS One. 2019;14:e0220418.

  17. Retraction: Salvage Liver Transplantation for Recurrent Hepatocellular Carcinoma after Liver Resection: Retrospective Study of the Milan and Hangzhou Criteria.
    PLoS One. 2019;14:e0220431.

  18. Retraction: Salvage Liver Transplantation for Patients with Recurrent Hepatocellular Carcinoma after Curative Resection.
    PLoS One. 2019;14:e0220394.

  19. BECKER F, Voss T, Mohr A, Mehdorn AS, et al
    Impact of nighttime procedures on outcomes after liver transplantation.
    PLoS One. 2019;14:e0220124.
    PubMed     Abstract available

  20. Retraction: Symptom Experienced Three Years after Liver Transplantation under Immunosuppression in Adults.
    PLoS One. 2019;14:e0220872.

  21. MORIS D, Kostakis ID, Machairas N, Prodromidou A, et al
    Comparison between liver transplantation and resection for hilar cholangiocarcinoma: A systematic review and meta-analysis.
    PLoS One. 2019;14:e0220527.
    PubMed     Abstract available

  22. Retraction: Genetic Polymorphism of Interferon Regulatory Factor 5 (IRF5) Correlates with Allograft Acute Rejection of Liver Transplantation.
    PLoS One. 2019;14:e0220815.

  23. Retraction: Identification of Histone Deacetylase 3 as a Biomarker for Tumor Recurrence Following Liver Transplantation in HBV-Associated Hepatocellular Carcinoma.
    PLoS One. 2019;14:e0220822.

  24. PASSOV A, Schramko A, Makisalo H, Nordin A, et al
    Graft glycocalyx degradation in human liver transplantation.
    PLoS One. 2019;14:e0221010.
    PubMed     Abstract available

  25. PFLUGRAD H, Tryc AB, Goldbecker A, Barg-Hock H, et al
    Cerebral metabolite alterations in patients with posttransplant encephalopathy after liver transplantation.
    PLoS One. 2019;14:e0221626.
    PubMed     Abstract available

  26. Retraction: The Survival Benefit of Liver Transplantation for Hepatocellular Carcinoma Patients with Hepatitis B Virus Infection and Cirrhosis.
    PLoS One. 2019;14:e0222176.

  27. Retraction: Artificial Liver Support System Combined with Liver Transplantation in the Treatment of Patients with Acute-on-Chronic Liver Failure.
    PLoS One. 2019;14:e0221917.

  28. Retraction: Association of MDR1 Gene SNPs and Haplotypes with the Tacrolimus Dose Requirements in Han Chinese Liver Transplant Recipients.
    PLoS One. 2019;14:e0220759.

  29. Retraction: Intraoperative Cryoprecipitate Transfusion and Its Association with the Incidence of Biliary Complications after Liver Transplantation-A Retrospective Cohort Study.
    PLoS One. 2019;14:e0222377.

  30. Retraction: New Diagnosis and Therapy Model for Ischemic-Type Biliary Lesions following Liver Transplantation-A Retrospective Cohort Study.
    PLoS One. 2019;14:e0222409.

  31. Retraction: The Ratio of Circulating Regulatory T Cells (Tregs)/Th17 Cells Is Associated with Acute Allograft Rejection in Liver Transplantation.
    PLoS One. 2019;14:e0222348.

  32. Retraction: Novel Single Nucleotide Polymorphisms in Interleukin 6 Affect Tacrolimus Metabolism in Liver Transplant Patients.
    PLoS One. 2019;14:e0222244.

  33. Retraction: Genetic Variations in Plasma Circulating DNA of HBV-Related Hepatocellular Carcinoma Patients Predict Recurrence after Liver Transplantation.
    PLoS One. 2019;14:e0222258.

  34. Retraction: Comparison of Steroid-Free Immunosuppression and Standard Immunosuppression for Liver Transplant Patients with Hepatocellular Carcinoma.
    PLoS One. 2019;14:e0222257.

  35. Retraction: Comprehensive Comparison of Three Different Immunosuppressive Regimens for Liver Transplant Patients with Hepatocellular Carcinoma: Steroid-Free Immunosuppression, Induction Immunosuppression and Standard Immunosuppression.
    PLoS One. 2019;14:e0222507.

  36. GOEDE LL, Pflugrad H, Schmitz B, Lanfermann H, et al
    Quantitative magnetic resonance imaging indicates brain tissue alterations in patients after liver transplantation.
    PLoS One. 2019;14:e0222934.
    PubMed     Abstract available

  37. BROCK GN, Washburn K, Marvin MR
    Use of rapid Model for End-Stage Liver Disease (MELD) increases for liver transplant registrant prioritization after MELD-Na and Share 35, an evaluation using data from the United Network for Organ Sharing.
    PLoS One. 2019;14:e0223053.
    PubMed     Abstract available

  38. KWON J, Kim S, Yoo H, Lee E, et al
    Nimesulide-induced hepatotoxicity: A systematic review and meta-analysis.
    PLoS One. 2019;14:e0209264.
    PubMed     Abstract available

  39. BUCHER JN, Koenig M, Schoenberg MB, Crispin A, et al
    Liver transplantation in patients with a history of migration-A German single center comparative analysis.
    PLoS One. 2019;14:e0224116.
    PubMed     Abstract available

  40. LUMLEY S, Green C, Rafferty H, Smith C, et al
    Cytomegalovirus viral load parameters associated with earlier initiation of pre-emptive therapy after solid organ transplantation.
    PLoS One. 2019;14:e0210420.
    PubMed     Abstract available

  41. SENDRA L, Herrero MJ, Montalva EM, Noguera I, et al
    Efficacy of interleukin 10 gene hydrofection in pig liver vascular isolated 'in vivo' by surgical procedure with interest in liver transplantation.
    PLoS One. 2019;14:e0224568.
    PubMed     Abstract available

  42. ERHARTOVA D, Cahova M, Dankova H, Heczkova M, et al
    Serum miR-33a is associated with steatosis and inflammation in patients with non-alcoholic fatty liver disease after liver transplantation.
    PLoS One. 2019;14:e0224820.
    PubMed     Abstract available

  43. Retraction: Pathological Roles of Interleukin-22 in the Development of Recurrent Hepatitis C after Liver Transplantation.
    PLoS One. 2019;14:e0225971.

  44. OLDANI G, Peloso A, Slits F, Gex Q, et al
    The impact of short-term machine perfusion on the risk of cancer recurrence after rat liver transplantation with donors after circulatory death.
    PLoS One. 2019;14:e0224890.
    PubMed     Abstract available

  45. Retraction: Circulating FoxP3+ regulatory T and interleukin17-producing Th17 cells actively influence HBV clearance in de novo Hepatitis B virus infected patients after orthotopic liver transplantation.
    PLoS One. 2019;14:e0226148.

  46. PARK J, Lim SJ, Choi HJ, Hong SH, et al
    Predictive utility of the C-reactive protein to albumin ratio in early allograft dysfunction in living donor liver transplantation: A retrospective observational cohort study.
    PLoS One. 2019;14:e0226369.
    PubMed     Abstract available

  47. NUNEZ KG, Frank A, Gonzalez-Rosario J, Galliano G, et al
    Interleukin-33 / Cyclin D1 imbalance in severe liver steatosis predicts susceptibility to ischemia reperfusion injury.
    PLoS One. 2019;14:e0216242.
    PubMed     Abstract available

  48. BRAL M, Aboelnazar N, Hatami S, Thiesen A, et al
    Clearance of transaminases during normothermic ex situ liver perfusion.
    PLoS One. 2019;14:e0215619.
    PubMed     Abstract available

  49. KONG J, Wang T, Shen S, Zhang Z, et al
    A nomogram predicting the prognosis of young adult patients diagnosed with hepatocellular carcinoma: A population-based analysis.
    PLoS One. 2019;14:e0219654.
    PubMed     Abstract available

  50. SENKERIKOVA R, Frankova S, Jirsa M, Kreidlova M, et al
    PNPLA3 rs738409 G allele carriers with genotype 1b HCV cirrhosis have lower viral load but develop liver failure at younger age.
    PLoS One. 2019;14:e0222609.
    PubMed     Abstract available

  51. NOSTEDT JJ, Churchill T, Ghosh S, Thiesen A, et al
    Avoiding initial hypothermia does not improve liver graft quality in a porcine donation after circulatory death (DCD) model of normothermic perfusion.
    PLoS One. 2019;14:e0220786.
    PubMed     Abstract available

  52. BOTEON YL, Laing RW, Schlegel A, Wallace L, et al
    The impact on the bioenergetic status and oxidative-mediated tissue injury of a combined protocol of hypothermic and normothermic machine perfusion using an acellular haemoglobin-based oxygen carrier: The cold-to-warm machine perfusion of the liver.
    PLoS One. 2019;14:e0224066.
    PubMed     Abstract available

  53. SHONAKA T, Matsuno N, Obara H, Yoshikawa R, et al
    Impact of human-derived hemoglobin based oxygen vesicles as a machine perfusion solution for liver donation after cardiac death in a pig model.
    PLoS One. 2019;14:e0226183.
    PubMed     Abstract available

  54. BRAL M, Pawlick R, Marfil-Garza B, Dadheech N, et al
    Pan-caspase inhibitor F573 mitigates liver ischemia reperfusion injury in a murine model.
    PLoS One. 2019;14:e0224567.
    PubMed     Abstract available

  55. BAJAJ JS, Fan S, Thacker LR, Fagan A, et al
    Serum and urinary metabolomics and outcomes in cirrhosis.
    PLoS One. 2019;14:e0223061.
    PubMed     Abstract available

    January 2018
  56. SCHREIBER PW, Bischoff-Ferrari HA, Boggian K, Bonani M, et al
    Bone metabolism dynamics in the early post-transplant period following kidney and liver transplantation.
    PLoS One. 2018;13:e0191167.
    PubMed     Abstract available

  57. MAROT A, Dubois M, Trepo E, Moreno C, et al
    Liver transplantation for alcoholic hepatitis: A systematic review with meta-analysis.
    PLoS One. 2018;13:e0190823.
    PubMed     Abstract available

  58. SZYMCZAK M, Kalicinski P, Kowalewski G, Broniszczak D, et al
    Acute liver failure in children-Is living donor liver transplantation justified?
    PLoS One. 2018;13:e0193327.
    PubMed     Abstract available

  59. ANDRES A, Montano-Loza A, Greiner R, Uhlich M, et al
    A novel learning algorithm to predict individual survival after liver transplantation for primary sclerosing cholangitis.
    PLoS One. 2018;13:e0193523.
    PubMed     Abstract available

  60. CZIGANY Z, Bleilevens C, Beckers C, Stoppe C, et al
    Limb remote ischemic conditioning of the recipient protects the liver in a rat model of arterialized orthotopic liver transplantation.
    PLoS One. 2018;13:e0195507.
    PubMed     Abstract available

  61. CHAE MS, Moon KU, Chung HS, Park CS, et al
    Serum interleukin-6 and tumor necrosis factor-alpha are associated with early graft regeneration after living donor liver transplantation.
    PLoS One. 2018;13:e0195262.
    PubMed     Abstract available

  62. BRYCE CL, Chang CCH, Ren Y, Yabes J, et al
    Using time-varying models to estimate post-transplant survival in pediatric liver transplant recipients.
    PLoS One. 2018;13:e0198132.
    PubMed     Abstract available

  63. BECKER F, Vogel T, Voss T, Mehdorn AS, et al
    The weekend effect in liver transplantation.
    PLoS One. 2018;13:e0198035.
    PubMed     Abstract available

  64. GROTTENTHALER JM, Werner CR, Steurer M, Spengler U, et al
    Successful direct acting antiviral (DAA) treatment of HCV/HIV-coinfected patients before and after liver transplantation.
    PLoS One. 2018;13:e0197544.
    PubMed     Abstract available

  65. SHAHEEN AA, Kaplan GG, Almishri W, Vallerand I, et al
    The impact of depression and antidepressant usage on primary biliary cholangitis clinical outcomes.
    PLoS One. 2018;13:e0194839.
    PubMed     Abstract available

  66. EYRAUD D, Suner L, Dupont A, Bachelot-Loza C, et al
    Evolution of platelet functions in cirrhotic patients undergoing liver transplantation: A prospective exploration over a month.
    PLoS One. 2018;13:e0200364.
    PubMed     Abstract available

  67. DU Z, Dong J, Bi J, Bai R, et al
    Predictive value of the preoperative neutrophil-to-lymphocyte ratio for the development of hepatocellular carcinoma in HBV-associated cirrhotic patients after splenectomy.
    PLoS One. 2018;13:e0195336.
    PubMed     Abstract available

  68. LEE SH, Park M, Park KM, Gwag HB, et al
    Corrected QT interval on the electrocardiogram after liver transplantation: Surrogate marker of poor clinical outcomes?
    PLoS One. 2018;13:e0206463.
    PubMed     Abstract available

  69. SILVA VIEIRA M, Arthurs CJ, Hussain T, Razavi R, et al
    Patient-specific modeling of right coronary circulation vulnerability post-liver transplant in Alagille's syndrome.
    PLoS One. 2018;13:e0205829.
    PubMed     Abstract available

  70. NAVARRO-ALVAREZ N, Machaidze Z, Schuetz C, Zhu A, et al
    Xenogeneic Heterotopic Auxiliary Liver transplantation (XHALT) promotes native liver regeneration in a Post-Hepatectomy Liver failure model.
    PLoS One. 2018;13:e0207272.
    PubMed     Abstract available

  71. CHIANG HC, Chien YC, Lin PY, Lee HL, et al
    Assessing men with erectile dysfunction before and after living donor liver transplantation in real-world practice: Integrating laboratories into clinical settings.
    PLoS One. 2018;13:e0206438.
    PubMed     Abstract available

  72. CHAE MS, Park H, Choi HJ, Park M, et al
    Role of serum levels of intraoperative brain natriuretic peptide for predicting acute kidney injury in living donor liver transplantation.
    PLoS One. 2018;13:e0209164.
    PubMed     Abstract available

  73. SALZBERGER W, Martrus G, Bachmann K, Goebels H, et al
    Tissue-resident NK cells differ in their expression profile of the nutrient transporters Glut1, CD98 and CD71.
    PLoS One. 2018;13:e0201170.
    PubMed     Abstract available

  74. ABUDHAISE H, Davidson BR, DeMuylder P, Luong TV, et al
    Evolution of dynamic, biochemical, and morphological parameters in hypothermic machine perfusion of human livers: A proof-of-concept study.
    PLoS One. 2018;13:e0203803.
    PubMed     Abstract available

    January 2017
  75. SALDANA RS, Schrem H, Barthold M, Kaltenborn A, et al
    Prognostic Abilities and Quality Assessment of Models for the Prediction of 90-Day Mortality in Liver Transplant Waiting List Patients.
    PLoS One. 2017;12:e0170499.
    PubMed     Abstract available

  76. CROOME KP, Lee DD, Harnois D, Taner CB, et al
    Effects of the Share 35 Rule on Waitlist and Liver Transplantation Outcomes for Patients with Hepatocellular Carcinoma.
    PLoS One. 2017;12:e0170673.
    PubMed     Abstract available

  77. BASHIR A, Attie O, Sullivan M, Sebra R, et al
    Genomic confirmation of vancomycin-resistant Enterococcus transmission from deceased donor to liver transplant recipient.
    PLoS One. 2017;12:e0170449.
    PubMed     Abstract available

  78. STRATIGOPOULOU P, Paul A, Hoyer DP, Kykalos S, et al
    High MELD score and extended operating time predict prolonged initial ICU stay after liver transplantation and influence the outcome.
    PLoS One. 2017;12:e0174173.
    PubMed     Abstract available

  79. GONZALEZ R, De la Rosa AJ, Rufini A, Rodriguez-Hernandez MA, et al
    Role of p63 and p73 isoforms on the cell death in patients with hepatocellular carcinoma submitted to orthotopic liver transplantation.
    PLoS One. 2017;12:e0174326.
    PubMed     Abstract available

  80. PEREZ P, Rodriguez-Peralvarez M, Guerrero L, Gonzalez V, et al
    Incidental hepatocellular carcinoma after liver transplantation: Prevalence, histopathological features and prognostic impact.
    PLoS One. 2017;12:e0175010.
    PubMed     Abstract available

  81. GERTH HU, Pohlen M, Tholking G, Pavenstadt H, et al
    Molecular adsorbent recirculating system (MARS) in acute liver injury and graft dysfunction: Results from a case-control study.
    PLoS One. 2017;12:e0175529.
    PubMed     Abstract available

  82. WANG C, Yang Y, Sun D, Jiang Y, et al
    Prognosis of hepatocellular carcinoma patients with bile duct tumor thrombus after hepatic resection or liver transplantation in Asian populations: A meta-analysis.
    PLoS One. 2017;12:e0176827.
    PubMed     Abstract available

  83. PARK J, Lee SH, Han S, Jee HS, et al
    Preoperative cardiac troponin level is associated with all-cause mortality of liver transplantation recipients.
    PLoS One. 2017;12:e0177838.
    PubMed     Abstract available

  84. ANDREOLI MCC, Souza NKG, Ammirati AL, Matsui TN, et al
    Predictors of renal function recovery among patients undergoing renal replacement therapy following orthotopic liver transplantation.
    PLoS One. 2017;12:e0178229.
    PubMed     Abstract available

  85. LI Q, Wang Y, Ma T, Liu X, et al
    Impact of cigarette smoking on early complications after liver transplantation: A single-center experience and a meta-analysis.
    PLoS One. 2017;12:e0178570.
    PubMed     Abstract available

  86. RUSSELLI G, Pizzillo P, Iannolo G, Barbera F, et al
    HCV replication in gastrointestinal mucosa: Potential extra-hepatic viral reservoir and possible role in HCV infection recurrence after liver transplantation.
    PLoS One. 2017;12:e0181683.
    PubMed     Abstract available

  87. HUGHES MG JR, Tucker WW, Reddy S, Brier ME, et al
    Rate of hepatitis C viral clearance by human livers in human patients: Liver transplantation modeling primary infection and implications for studying entry inhibition.
    PLoS One. 2017;12:e0180719.
    PubMed     Abstract available

  88. BARON-STEFANIAK J, Schiefer J, Miller EJ, Berlakovich GA, et al
    Comparison of macrophage migration inhibitory factor and neutrophil gelatinase-associated lipocalin-2 to predict acute kidney injury after liver transplantation: An observational pilot study.
    PLoS One. 2017;12:e0183162.
    PubMed     Abstract available

  89. STAHMEYER JT, Rossol S, Liersch S, Guerra I, et al
    Cost-Effectiveness of Treating Hepatitis C with Sofosbuvir/Ledipasvir in Germany.
    PLoS One. 2017;12:e0169401.
    PubMed     Abstract available

  90. WENG LC, Huang HL, Tsai HH, Lee WC, et al
    Predictors of decision ambivalence and the differences between actual living liver donors and potential living liver donors.
    PLoS One. 2017;12:e0175672.
    PubMed     Abstract available

  91. VAN RIJN R, Hoogland PER, Lehner F, van Heurn ELW, et al
    Long-term results after transplantation of pediatric liver grafts from donation after circulatory death donors.
    PLoS One. 2017;12:e0175097.
    PubMed     Abstract available

  92. JOCHMANS I, Monbaliu D, Ceulemans LJ, Pirenne J, et al
    Simultaneous liver kidney transplantation and (bilateral) nephrectomy through a midline is feasible and safe in polycystic disease.
    PLoS One. 2017;12:e0174123.
    PubMed     Abstract available

  93. UITTE DE WILLIGE S, Keane FM, Bowen DG, Malfliet JJMC, et al
    Circulating fibroblast activation protein activity and antigen levels correlate strongly when measured in liver disease and coronary heart disease.
    PLoS One. 2017;12:e0178987.
    PubMed     Abstract available

  94. BHAT M, Tazari M, Sebastiani G
    Performance of transient elastography and serum fibrosis biomarkers for non-invasive evaluation of recurrent fibrosis after liver transplantation: A meta-analysis.
    PLoS One. 2017;12:e0185192.
    PubMed     Abstract available

  95. SCHLEGEL V, Treuner-Kaueroff T, Seehofer D, Berg T, et al
    Low PCSK9 levels are correlated with mortality in patients with end-stage liver disease.
    PLoS One. 2017;12:e0181540.
    PubMed     Abstract available

  96. RODRIGUEZ K, Srivaths PR, Tal L, Watson MN, et al
    Regional citrate anticoagulation for continuous renal replacement therapy in pediatric patients with liver failure.
    PLoS One. 2017;12:e0182134.
    PubMed     Abstract available

  97. RENDON JC, Cortes-Mancera F, Restrepo-Gutierrez JC, Hoyos S, et al
    Molecular characterization of occult hepatitis B virus infection in patients with end-stage liver disease in Colombia.
    PLoS One. 2017;12:e0180447.
    PubMed     Abstract available

  98. MARTRUS G, Kautz T, Lunemann S, Richert L, et al
    Proliferative capacity exhibited by human liver-resident CD49a+CD25+ NK cells.
    PLoS One. 2017;12:e0182532.
    PubMed     Abstract available

  99. TSAI DF, Huang SW, Holm S, Lin YP, et al
    The outcomes and controversies of transplant tourism-Lessons of an 11-year retrospective cohort study from Taiwan.
    PLoS One. 2017;12:e0178569.
    PubMed     Abstract available

  100. KIM BH, Choi HY, Ki M, Kim KA, et al
    Population-based prevalence, incidence, and disease burden of autoimmune hepatitis in South Korea.
    PLoS One. 2017;12:e0182391.
    PubMed     Abstract available

  101. DULTZ G, Graubard BI, Martin P, Welker MW, et al
    Liver transplantation for chronic hepatitis C virus infection in the United States 2002-2014: An analysis of the UNOS/OPTN registry.
    PLoS One. 2017;12:e0186898.
    PubMed     Abstract available

  102. MARTINELLI I, Ponziani FR, Maino A, Bhoori S, et al
    Thrombosis after liver transplantation for hepatocellular carcinoma.
    PLoS One. 2017;12:e0186699.
    PubMed     Abstract available

  103. MAROT A, Henrion J, Knebel JF, Moreno C, et al
    Alcoholic liver disease confers a worse prognosis than HCV infection and non-alcoholic fatty liver disease among patients with cirrhosis: An observational study.
    PLoS One. 2017;12:e0186715.
    PubMed     Abstract available

  104. FIGORILLI F, Putignano A, Roux O, Houssel-Debry P, et al
    Development of an organ failure score in acute liver failure for transplant selection and identification of patients at high risk of futility.
    PLoS One. 2017;12:e0188151.
    PubMed     Abstract available

  105. VOGEL T, Brockmann JG, Pigott D, Neil DAH, et al
    Successful transplantation of porcine liver grafts following 48-hour normothermic preservation.
    PLoS One. 2017;12:e0188494.
    PubMed     Abstract available

    January 2016
  106. CHENG CW, Liu FC, Lin JR, Tsai YF, et al
    The Impact of Hospital/Surgeon Volume on Acute Renal Failure and Mortality in Liver Transplantation: A Nationwide Cohort Study.
    PLoS One. 2016;11:e0162992.
    PubMed     Abstract available

  107. PARK M, Han S, Kim GS, Gwak MS, et al
    Evaluation of New Calibrated Pulse-Wave Analysis (VolumeViewTM/EV1000TM) for Cardiac Output Monitoring Undergoing Living Donor Liver Transplantation.
    PLoS One. 2016;11:e0164521.
    PubMed     Abstract available

  108. MUDUMA G, Saunders R, Odeyemi I, Pollock RF, et al
    Systematic Review and Meta-Analysis of Tacrolimus versus Ciclosporin as Primary Immunosuppression After Liver Transplant.
    PLoS One. 2016;11:e0160421.
    PubMed     Abstract available

  109. ROGAL SS, Mankaney G, Udawatta V, Chinman M, et al
    Pre-Transplant Depression Is Associated with Length of Hospitalization, Discharge Disposition, and Survival after Liver Transplantation.
    PLoS One. 2016;11:e0165517.
    PubMed     Abstract available

  110. HRYDZIUSZKO O, Perera MT, Laing R, Kirwan J, et al
    Mass Spectrometry Based Metabolomics Comparison of Liver Grafts from Donors after Circulatory Death (DCD) and Donors after Brain Death (DBD) Used in Human Orthotopic Liver Transplantation.
    PLoS One. 2016;11:e0165884.
    PubMed     Abstract available

  111. LANKARANI KB, Malek-Hosseini SA, Nikeghbalian S, Dehghani M, et al
    Fourteen Years of Experience of Liver Transplantation for Wilson's Disease; a Report on 107 Cases from Shiraz, Iran.
    PLoS One. 2016;11:e0167890.
    PubMed     Abstract available

  112. BREIL T, Wenning D, Teufel U, Hoffmann GF, et al
    An Assessment of Publication Status of Pediatric Liver Transplantation Studies.
    PLoS One. 2016;11:e0168251.
    PubMed     Abstract available

  113. AIKEN T, Garber A, Thomas D, Hamon N, et al
    Donor IFNL4 Genotype Is Associated with Early Post-Transplant Fibrosis in Recipients with Hepatitis C.
    PLoS One. 2016;11:e0166998.
    PubMed     Abstract available

  114. NUNEZ-TORRES R, Macias J, Mancebo M, Frias M, et al
    The PNPLA3 Genetic Variant rs738409 Influences the Progression to Cirrhosis in HIV/Hepatitis C Virus Coinfected Patients.
    PLoS One. 2016;11:e0168265.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Liver Transplantation is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.